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Purpose: Adenoviral keratoconjunctivitis is a major cause of ocular morbidity and may lead to visual loss. Adenovirus
types 8, 19, and 37 may cause epidemic keratoconjunctivitis. The main objective of this study was to determine the types
of adenoviruses causing keratoconjunctivitis in Saudi Arabia.
Methods: We conducted a non-interventional observational clinical study. Seventy three eyes from 65 patients who
presented to The Eye Center in Riyadh, Saudi Arabia with clinical features of acute adenoviral keratoconjunctivitis were
included. Each patient underwent complete clinical examination and features such as membranous reaction, conjunctival
hemorrhage, subepithelial corneal infiltrates, and preauricular lymph node enlargement were recorded. Conjunctival swabs
were obtained from patients with presumed acute viral conjunctivitis. Immunochromatography (IC) and restriction
fragment length polymorphism polymerase chain reaction (PCR-RFLP) were performed on the conjunctival swabs
obtained from each eye. Serotype identification was performed using direct sequencing technique.
Results: Forty-nine (67.1%) were adenovirus type 8, 8 (11.0%) were adenovirus type 3, 6 (8.2%) type 37, 5 (6.8%) were
adenovirus type 4, and 2 (2.3%) type 19. The remaining 5 were types 14, 19, and 22. The prevalence of membranous
conjunctivitis was highest (83%) among eyes with adenovirus type 37 while subepithelial corneal opacities were most
commonly seen among eyes with adenovirus type 8 (47%). Immunochromatography tests were positive for adenovirus
in 48 (65.7%) out of 73 eyes.
Conclusions: This study determined the types of adenoviruses causing keratoconjunctivitis at one center in Saudi Arabia.
Direct sequencing techniques is an efficient, accurate, and rapid means of diagnosing adenoviral keratoconjunctivitis. The
most common causes of adenoviral keratoconjunctivitis in Saudi Arabia were adenovirus types 8, 3, and 37. Membranous
conjunctivitis and subepithelial opacities had the highest frequency of adenovirus types 37 and 8, respectively. Lymph
nodes enlargement was least likely in adenovirus type 4.
Adenoviral  keratoconjunctivitis  is  a  common  viral
infection  of  the  ocular  surface  and  has  a  worldwide
distribution. Certain adenovirus serotypes are non-pathogenic
but a few infection in the eye can be in the form are associated
with clinical diseases [1,2]. Adenoviral infection in the eye
can be in the form of epidemic keratoconjunctivitis (EKC),
pharyngoconjunctival fever, and non-specific conjunctivitis
[3].The  most  common  adenoviral  serotypes  that  cause
epidemic  keratoconjunctivitis  in  order  of  frequency,  are
adenovirus types 8, 19, 37, and 5. The clinical manifestations
of the disease may vary. For an instance, certain virus types
cause  corneal  involvement  and  affect  vision  while  others
cause conjunctivitis without corneal involvement. In general,
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the  diagnosis  of  adenoviral  keratoconjunctivitis  is  made
clinically but often there is conjunctival edema along with
follicular  reaction  and  hemorrhage  [4].  Patients  may  also
experience  itching,  pain  and  discharge.  In  severe  cases,
inflammatory membrane and conjunctival hemorrhage may
develop. Corneal involvement gives rise to blurring of vision.
Saudi Arabia, as a host country for the Muslim pilgrims
performing Hajj and Omra, becomes the destination of people
from all over the world particularly during certain seasons of
the year. This has contributed various health impacts to the
local  population.  One  of  the  effects  was  wide  range  of
infectious  organisms  including  the  adenoviral
keratoconjunctivitis. The serotypes of adenovirus are thought
to be different as varied clinico-pathological manifestations
were observed. To date, there has been no study to describe
the clinical manifestations of adenoviral keratoconjunctivitis
and  their  correlations  with  adenoviral  serotypes  in  Saudi
Arabia.
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adenovirus  serotypes  and  clinical  manifestations  of
adenoviral keratoconjunctivitis in Saudi Arabia.
METHODS
Study  design:  A  non-interventional  observational  clinical
study.
Patients: Seventy three eyes among 65 consecutive patients
who  were  diagnosed  with  adenoviral  keratoconjunctivitis
based on its clinical features in the period of 2002 to 2007
were included in this study. This study was approved by the
Institution Review Board (IRB) of The Eye Center, Riyadh,
Saudi  Arabia.  Patients  with  clinical  findings  of  sudden
redness,  discomfort,  pain,  tearing,  conjunctival  injection,
follicular  reaction,  and  tender  pre-auricular  lymph  node
enlargement and who had positive PCR for adenovirus were
included. Epidemiological data obtained included registration
number, age and gender. Each patient underwent complete
biomicroscopic  evaluation.  Eye  examinations  were
performed  by  one  of  us  (KFT).  Clinical  data  recorded
comprised  of  presence  or  absence  of  conjunctival
membranous  reaction,  conjunctival  hemorrhage,  corneal
subepithelial  infiltrate  and  preauricular  lymphadenopathy.
Patients were followed-up for a mean period of 14 months
(range: 6 to 18 months).
Specimens from the inferior palpebral conjunctiva were
obtained through conjunctival swabs. Specimens were stored
at −70 °C until time of processing. Polymerase chain reaction
(PCR)  was  done  using  restriction  fragment  length
polymorphism  (PCR-RFLP).  Serotype  identification  was
done  using  direct  sequencing  technique.
Immunochromatography (IC) test was also performed on all
conjunctival specimens.
PCR  technique  and  sequence  analysis:  Viral  DNA  was
extracted from 100 µl of the conjunctival specimen with a
Sumitest EX-R&D kit (Medical & Biologic Laboratories Co.,
Ltd.,  Nagano,  Japan),  according  to  the  manufacturer's
instructions. The extracted DNA was suspended in 100 µl of
TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). PCR was
performed in 50 µl of reaction mixture containing 5 µl of
extracted viral DNA, 5 µl of 10× Taq buffer, 200 µM each of
dATP, dGTP, and dTTP, 0.5 µM of each primer and 2.5 U of
Taq DNA polymerase (TaKaRa EX-Taq, Takara Bio Inc.,
Shiga, Japan). After initial denaturation at 94 °C for 5 min, 40
cycles of denaturing at 94 °C for 30 s, annealing at 50 °C for
30 s, and extension at 72 °C for 1 min, a final extension at
72 °C for 7 min was performed using a Gene Amp PCR
System 9600 (Applied Biosystems, Foster City, CA). The
primers  for  amplication  of  the  entire  hexon  were  AdVID
(nucleotides 17, 751–17, 772 of GenBank AF108105, 5′-TGT
ATG  TGC  CTT  ACG  GCC  AGA  G-3′)  and  aDl3d2
(nucleotides 20,642–20,611) of GenBank AF108105, 5′-GCG
CWC  GAT  GGR  CGC  RAG  CT-3′).  The  primers  for
amplification of the entire fiber were AdD1 (nucleotides 5–
25 of GenBank U69132, 5′-GAT GTC AAA TTC CTG GTT
CCA C-3′) and aDd2 (nucleotides 1196–1198 of GenBank
U69132, 5′-TAC CCG TGC TGG TGT AAA AAT C-3′). The
positions of the primers for PCR were numbered according to
the  complete  nucleotide  sequence  of  the  HAdV-2  strain
(GenBank J01917).
The PCR products from the hexon gene and fiber gene
were  separated  in  1%  agarose  gel  and  purified  with  a
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). The
nucleotide sequences of the entire hexon genes and the entire
fiber  genes  were  determined  with  a  CEQ  2000XL  DNA
Analysis System with Dye Terminator Cycle Sequencing Kit
(Beckman Coulter, Fullerton, CA). The primers used for cycle
sequencing were the same as those used for the PCR that is
described above.
Immunochromatography  test  (IC):  The
immunochromatography test (Adeno Test, SA Scientific, San
Antonio, TX) was performed according to the manufacturer's
instruction. Using a sterile swab, conjunctival specimen was
taken  from  the  lower  palpebral  conjunctiva  without
anesthesia.  This  was  followed  immediately  by  a  short
extraction step using a buffer solution. Using the specimen
pipettes provided, four drops of the specimen solution were
placed into the specimen well of the kit. Time was allowed for
the specimen to filter through the kit to the specimen position
and the control position. Appearance of a colored line at each
position was looked for. The test was considered to be positive
if lines were visible at the specimen and control positions. The
test was considered negative if line was visible only at the
control position. If no line was visible, the test was considered
invalid and repeat test was performed for the same specimen.
Readings were finalized not more than thirty minutes from
application of specimen to the kit. A consent was obtained
from  each  patient  and  Institution  Review  Board  (IRB)
approved this study.
RESULTS
Age and gender distributions: The patients' age range was
from 2 to 63 years with a mean age of 28.00±13.68 years.
There were 33 (50.8%) males and 32 (49.2%) females in this
study.  Eight  (5.2%)  patients  had  bilateral  involvement  at
presentation and both eyes were included separately in the
study.
Adenoviral serotypes: A total of 73 eyes of 65 patients showed
positive  PCR  There  were  seven  adenoviral  serotypes
identified causing adenoviral keratoconjunctivitis among the
entire subjects in this study. Adenovirus (Ad) serotype 3 was
found in 8 (11%) eyes, Ad4 in 5 (6.8%) eyes, Ad8 in 49
(67.1%), and Ad37 in 6 (8.2%). Other serotypes identified
were Ad14 (1 eye, 1.4%), Ad19 (2 eyes, 2.7%), and Ad22 (2
eyes, 2.7%).
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throughout all age groups. We noted that Ad3 and Ad4 did not
occur in patients above 40 years while Ad37 did not occur in
patient 20 years or less. There was no statistically significant
association between the age and the different serotypes of
adenoviral keratoconjunctivitis (λ2=10.68, p=0.56).
Gender  and  serotypes:  All  adenoviral  serotypes  were
distributed  equally  among  both  genders.  There  was  no
statistically significant association found between gender and
serotypes  of  adenoviral  keratoconjunctivitis  (λ2=6.254,
p=0.181).
Adenotest and serotypes: Positive immunochromatography
test  rate  was  highest  in  adenoviral  serotype  37  (83.3%)
followed  by  Ad8  (71.43%),  Ad3  (50%),  and  Ad4  (40%).
There  was  no  statistically  significant  difference  between
positive  immunochromatography  test  result  and  different
adenoviral  serotypes  in  patients  with  keratoconjunctivitis
(λ2=3.971,  p=0.410).  The  distribution  of  adenoviral
immunochromatography test result across different type of
adenoviral serotypes is shown in Figure 1.
Clinical features and serotypes: Corneal involvement in the
form of subepithelial infiltrate was found in 30 (41.1%) eyes
with keratoconjunctivitis. Highest prevalence was recorded in
Ad8  with  48.98%.  There  was  no  statistically  significant
association between presence of cornea subepithelial opacity
and adenoviral serotypes (λ2=5,032, p=0.284).
Membranous reaction was observed in 33 (45.2%) out of
73 eyes. Highest prevalence of membranous conjunctivitis
among the adenovirus serotypes was recorded in Ad37 with
83.33%.  There  was  no  statistically  significant  association
between membranous reaction and adenoviral serotypes in
our study population (λ2=8.760, p=0.067).
Conjunctival hemorrhage was a feature in 42 (57.5%)
eyes.  Although  prevalence  was  recorded  highest  in  Ad8
(65%), there was no statistically significant association found
between presence of conjunctival hemorrhage and serotypes
of adenoviral keratoconjunctivitis (λ2=5.561, p=0.234).
Figure 1. Distribution of immunochromatography result according
to adenoviral serotypes among 73 ocular specimens.
Preauricular lymphadenitis occurred in 58 (79.5%) eyes.
Prevalence was recorded the lowest in Ad4 (20%). There was
a  statistically  significant  association  between  presence  of
lymphadenitis  and  serotypes  of  adenoviral
keratoconjunctivitis (λ2=13.593, p=0.009).
The prevalence of various clinical features in different
adenoviral serotypes are summarized in Table 1.
DISCUSSION
Adenoviruses are large unenveloped double-stranded DNA
viruses known to cause diseases of the respiratory tract, eyes,
gastrointestinal tract and genitourinary tract in human. To
date, there have been over 50 antigenically distinct adenovirus
serotypes  discovered  based  on  neutralization  techniques.
They are subdivided into six subgenera A-F according to their
ability to agglutinate red blood cells and their DNA homology
[5-7].
Adenovirus detection can be performed using several
methods. The gold standard is virus isolation followed by
observation  of  cytopathic  effect,  in  susceptible  cell  line.
Although isolation of virus is definitive and allows further
characterization, it is considered costly and time consuming.
Culture was reported to take a range of 3 to 29 days with mean
of 9.1 days [2,7,8]. Saitoh-Inagawa et al. [9] reported that it
took three days to identify adenovirus serotypes by PCR-
RFLP as compared to at least three weeks by culture isolation
and neutralization test. Shell vial technique is a cell culture
method that uses centrifugation and immunofluorescence to
shorten culture positive time. In addition to being definitive,
it  provides  positive  results  in  shorter  time  than  in  the
conventional cell culture [10].
Immunochromatography (IC) and enzyme immunoassay
(EIA)  for  adenovirus  have  been  described  with  variable
sensitivity  and  specificity.  Uchio  et  al.  [11]  reported
sensitivity of 54% and specificity of 97.1% for IC. On the
other  hand,  the  sensitivity  and  specificity  of  EIA  were
reported to be 50.5% and 100%, respectively. While both tests
were easier to be conducted, IC has the added advantage of
providing faster result [8,11]. The PCR with the advantages
of faster, more accurate and improved sensitivity, has been the
method of choice lately. Sensitivity and specificity of the
newer multiplex PCR has been shown to approach 100%.
However,  it  has  the  disadvantages  of  high  technical  and
expertise demand apart from high cost [2,3,8,11,12,13]. PCR-
RFLP has the disadvantage of inability to identify adenovirus
serotypes if a mutation in the restriction enzyme-cutting sites
occur. PCR-sequencing may be useful to obtain more accurate
serotyping [14,15].
Adenoviral conjunctivitis is largely caused by adenovirus
serotypes  3,  4,  8,  19,  22  and  37  [9,10,15,16].  EKC  is
commonly caused by subgroup D Adenovirus particularly
serotype  8,  19,  and  37,  often  without  systemic  syndrome
association [2,3,8,16]. Adenovirus serotypes 3, 4, 7, and 11
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Adenovirus  serotype  4  (Ad4)  has  broad  symptomatology
ranging  from  pharyngoconjunctival  fever  to  adenoviral
keratoconjunctivitis [17]. Ad4 has also been regarded as one
of the major isolates in the adenoviral keratoconjunctivitis
[18].
Jin  et  al.  [19]  conducted  a  study  to  investigate  the
epidemiology of adenoviral conjunctivitis in Hanoi, Vietnam
and reported predominantly high prevalence of Ad8 (n=11,
78.6%) from fourteen PCR-positive conjunctival specimens.
Other adenoviral serotypes found in their study were Ad3
(n=2, 14.3%) and Ad37 (n=1, 7.1%) [19]. Aoki et al. [20]
reported  prevalence  of  Ad8  in  124  (63.26%),  Ad3  in  24
(12.24%), Ad4 in 33 (16.84%), and Ad19 in 15 (7.65%) of
196 PCR positive conjunctival specimens. Ishii et al. [21]
compared  the  clinical  and  viral  data  of  adenoviral
keratoconjunctivitis in three east Asian cities, found Ad8 as
the main serotypes in Sapporo (Japan), Koahsiung (Taiwan),
and  Busan  (Korea).  Other  serotypes  included  Ad3,  Ad4,
Ad11, Ad19, and Ad37; each of which encountered for less
10% of cases [21].
Saitoh-Inagawa [22] in a study in Sapporo over 10 year
period found Ad4 as the most common serotype and Ad3,
Ad8, Ad11, Ad19, and Ad37 occurred less frequently. We
experienced  the  similar  pattern  of  adenovirus  serotypes
distribution among our patients. Ad8 was found to be the most
frequent serotypes (49 eyes, 67.1%) in our study although the
rate of Ad19 keratoconjunctivitis was relatively low (2 eyes,
2.3%).
IC for adenoviral in this study has been shown to be
positive in 67% of PCR positive specimens. All specimens
positive for IC were also positive for PCR which reflect high
specificity. These finding are consistent with those reported
by Jin et al. [19] and Levent et al. [23]. Adeno-check was
developed  for  rapid  diagnosis  of  human  adenovirus  by
immunochromatography.  However,  it  had  low  sensitivity
although  specificity  was  high.  A  later  version,  modified
Adeno-check,  was  introduced  to  improve  this  drawback.
Toshihide [24] compared the regular and modified versions
regarding the sensitivity against adenoviral culture positive
specimen from the conjunctiva. Regular version of Adeno-
check showed 33 samples (48.5%) as positive compared to
modified version which turned to be positive in 50 (73.5%)
samples (p<0.01). They concluded that modified version was
more sensitive than the regular version in the detection of
human adenovirus [24].
Although  adenovirus  serotypes  3,  7,  and  11  were
associated with pharyngoconjunctival fever in children and
serotypes  8,  19,  and  37  were  associated  with  epidemic
keratoconjunctivitis affecting adults, we did not find that age
was significantly associated with adenoviral serotypes among
our  keratoconjunctivitis  patients.  This  may  be  explained
partly by our small sample size and the possibility that patients
with pharyngoconjunctival fever presented themselves to the
physician  for  the  systemic  symptoms.Gender  was  not
associated  with  adenoviral  serotypes  in  adenoviral
keratoconjunctivitis in our study population, consistent with
the finding reported by Montessori et al. [25].
Conjunctival hemorrhage was reported to be present in
51.5% of PCR-proven conjunctivitis caused by Ad37 (68.1%)
and Ad19 (19.2%) [12]. We found conjunctival hemorrhage
in 57.5% eyes in Ad37 and Ad19. Lymphadenopathy was the
single  most  important  clinical  sign  in  association  with
different adenovirus serotype while inflammatory membrane
formation  was  less  common.  Other  clinical  features
investigated in this study were not significantly associated
with specific adenoviral serotypes.
Immunochromatography  test  using  commercially
available  kit  was  not  a  satisfactory  office  detection  for
adenovirus keratoconjunctivitis. Ad8 was the major serotype
causing  adenoviral  keratoconjunctivitis  in  Saudi  Arabia.
Corneal  involvement  and  conjunctival  hemorrhage  were
frequent in Ad8 and membranous reaction in Ad37. Larger
multi-center study is necessary to asses the clinicopathology
of adenoviral serotypes in keratoconjunctivitis. Subjects come
to Saudi Arabia from various regions around the world and
may bring with them viruses such as adenovirus. This may
have contributed to the spread of epidemics of adenoviral
keratoconjunctivitis.
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TABLE 1. NUMBER OF CLINICAL FEATURES ACCORDING TO DIFFERENT ADENOVIRUS SEROTYPES IN KERATOCONJUNCTIVITIS EYES.
  Adenoviral (Ad) serotypes
Clinical features Ad 3 (%) [n=8] Ad 4 (%) [n=5] Ad 8 (%) [n=49] Ad 37 (%) [n=6] Other (%) [n=5]
Corneal involvement 1 (12) 1 (20) 24 (49) 2 (33) 2 (40)
Membrane 1 (12) 1 (20) 23 (47) 5 (83) 3 (60)
Conjunctival hemorrhage 3 (38) 3 (60) 32 (65) 3 (50) 1 (20)
Lymph node swelling 6 (75) 1 (20) 43 (88) 4 (67) 4 (80)
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